Building on the findings from the SURMOUNT-OSA trial, which demonstrated tirzepatides efficacy in improving OSA in nondiabetic patients, this study investigated whether OSA modifies the mortality benefit associated with GLP-1 use among individuals with diabetes in a large, real-world population
Examining the Labels: Active Ingredients Behind the Hype These popular weight loss drugs share similarities in their active ingredients, particularly their ability to mimic hormones that regulate appetite and blood sugar
Individual results vary based on starting weight, dose, nutrition, movement, and adherence
Conversely, those with lower body weight may feel effects more quickly and more intensely because the concentration relative to their body mass is higher
For example, generic compounded semaglutide is $300 monthly and cant be covered by insurance
So I just decided to go off these drugs